Rating History for PhaseBio Pharmaceuticals Inc. (PHAS) by Stifel

More Stocks Rated by Stifel | Latest Ratings for PHAS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/28/2022 Annabel Samimy Downgrade Hold
(Buy)		 1.00
(N/A)		 0.76
(0.07)		 -90.79% Details